AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Patient-Reported Quality of Life After Open Surgery for Complex Abdominal Aortic Aneurysms: A Prospective Study

Recruitingn/aAges 18 Years - anyAllProuse Giorgio
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

STUDY DURATION: January 2026 - December 2027 Each participant will be followed for 12 months postoperatively. BACKGROUND AND RATIONALE: Complex abdominal aortic aneurysms (cAAAs)-including juxtarenal, pararenal, and suprarenal aneurysms-can be treated via open surgical repair (OSR) or complex endovascular techniques (f/bEVAR). While OSR may offer better long-term durability, especially in fit patients, there is currently a lack of data on patient-reported quality of life (QoL) outcomes following OSR for cAAAs. This study aims to fill this gap and support shared decision-making in vascular surgery. OBJECTIVES: * Primary Objective: To assess changes in health-related quality of life (HRQoL) using the Short Form-36 (SF-36) questionnaire at five predefined time points (baseline, discharge, 1 month, 6 months, and 12 months post-surgery). * Secondary Objectives: To analyze QoL differences b

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients over 18 years old * Patients undergoing open surgical repair for complex abdominal aortic aneurysms (AAAs), including juxtarenal, pararenal and suprarenal/paravisceral aneurysms * Patients treated for asymptomatic or symptomatic non ruptured aneurysms * Patients who are able and willing to provide informed, complete, and accurate responses to the SF-36 questionnaire Exclusion Criteria: * Patients under 18 years old * Patients treated for ruptured abdominal aortic aneurysms * Patients with incomplete data, or who denied consent * Patients with cognitive impairment or other conditions that prevent them from reliably completing the SF-36 questionnaires.
๐Ÿ’Š

What it tests

  • To assess changes in health-related quality of life (HRQoL) using the Short Form-36 (SF-36) questionnaire
๐Ÿ“

Where

2 sites
Luzerner Kantonspital
Lucerne, Switzerland
EOC - Ospedale Regionale di Lugano, Civico
Lugano, Switzerland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy